Retrospective analysis of hundred patients who had undergone lobectomy for lung cancer Akciǧer kanseri nedeniyle lobektomi uygulanan 100 olgunun retrospektif analizi

SAĞIROĞLU G., Meydan B., Iskenderoǧlu I., ÇOPUROĞLU E., Küpeli M., Tezel Ç., ...Daha Fazla

Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi, cilt.19, sa.1, ss.16-22, 2013 (Scopus)

Özet

Objective: Lung cancer, mostly non-small cell carcinoma is the leading cause of death(1). In this study, we investigated the risk factors that extend the duration of postoperative unit stay or increase the morbidity and mortality. Material and Methods: Between January 2009 and October 2009, patients had undergone lobectomy for lung cancer were retrospectively analyzed. Sex, age, smoking status, histopathology type, neoadjuvant treatment, comorbid diseases, FEV1, ASA (American Society of Anesthesiologists) score, side and type of lobectomy, duration of anesthesia under mechanical ventilation in ICU, number of transfusions, complications, length of ICU, and hospital stay and mortality rates were recorded. Results: In this study, preoperative mean FEV1 value was 79.7%. ASA scores were; 55 (55%) ASA I, 22 (22%) ASA II, 23 (23%) ASA III. The lengthy of anesthesia was 218.81±81 min. The development of BPF was significantly higher in 7% of the patients under neoadjuvant treatment (p<0.05) and at 14% of the patients transferred to the intensive care unit with a need of intubation tube. Sleeve resections (p<0.0001) and the presence of bronchopleural fistula (BPF)(p<0.05) were the factors that significantly increase mortality. The mean length of hospital stay was 8.3 days. Conclusion: We believe that the incidence of BPF affecting mortality after lobectomy for lung cancer can be reduced with careful anesthesia and attentive surgery.